The COVID-19 pandemic has made breast cancer patients even more vulnerable in their fight to defeat this illness. They are faced with many new limitations within their healthcare systems coupled with financial challenges in this uncertain economy.
To support our ongoing commitment to joining the fight, SHG surveyed 180 international Oncologists to bring forth the global impact COVID-19 continues to have on patient screening, diagnosis, and treatment recommendations. The Physicians participating in this survey agreed to donate their honorarium to their national organization for breast cancer research!
Download the report to see the survey results.